TY - JOUR
T1 - Molecular Genomic Testing for Breast Cancer
T2 - Utility for Surgeons
AU - Fayanju, Oluwadamilola M.
AU - Park, Ko Un
AU - Lucci, Anthony
N1 - Publisher Copyright:
© 2017, Society of Surgical Oncology.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Molecular genomic testing provides clinicians with both prognostic and (sometimes) predictive information that can help individualize treatment and decrease the risk of over- or under-treatment. We review the genomic tests that are currently available for clinical use in management of breast cancer, discuss ongoing research related to validating and expanding their utility in different patient populations, and explain why it is important for surgeons to know how to incorporate these tools into their clinical practice in order to individualize patient treatment, reduce unnecessary morbidity, and, accordingly, improve outcomes.
AB - Molecular genomic testing provides clinicians with both prognostic and (sometimes) predictive information that can help individualize treatment and decrease the risk of over- or under-treatment. We review the genomic tests that are currently available for clinical use in management of breast cancer, discuss ongoing research related to validating and expanding their utility in different patient populations, and explain why it is important for surgeons to know how to incorporate these tools into their clinical practice in order to individualize patient treatment, reduce unnecessary morbidity, and, accordingly, improve outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85034573400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034573400&partnerID=8YFLogxK
U2 - 10.1245/s10434-017-6254-z
DO - 10.1245/s10434-017-6254-z
M3 - Article
C2 - 29159748
AN - SCOPUS:85034573400
SN - 1068-9265
VL - 25
SP - 512
EP - 519
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 2
ER -